All of the following are true about Childhood Polycystic Kidney Disease, Except.
PKD is a genetic disorder. There are two main types: autosomal dominant and autosomal recessive. The autosomal recessive form is more common in children and is called ARPKD. It's caused by mutations in the PKHD1 gene. Symptoms in children might include enlarged kidneys, hepatic fibrosis, and sometimes pulmonary hypoplasia if the baby can't produce enough surfactant.
Now, the question asks which statement is not true. Let's think about common misconceptions. For example, ARPKD is often associated with cholestasis and liver disease. Another point is that it's a congenital condition, so the age of onset is different from the adult-onset ADPKD. Also, the inheritance pattern is autosomal recessive, so it's not something you see in every family unless both parents are carriers.
If the options include something like "it's autosomal dominant," that would be incorrect. Or if an option says it's caused by a different gene like PKD1, which is for ADPKD, that's wrong. Another wrong option might be that it's always asymptomatic at birth, but in reality, ARPKD can present with severe symptoms at birth.
Let me structure the explanation. The core concept is understanding the differences between ARPKD and ADPKD. The correct answer would be the one that incorrectly states an autosomal dominant inheritance or incorrect gene. The wrong options would be about symptoms, gene, or inheritance. The clinical pearl could be recognizing that ARPKD is a congenital disease with liver involvement.
**Core Concept**
Childhood Polycystic Kidney Disease (ARPKD) is an **autosomal recessive** disorder caused by mutations in the **PKHD1 gene**, leading to renal cyst formation and hepatic ductal plate malformation. It differs from adult-onset autosomal dominant PKD (ADPKD) in clinical presentation and genetic etiology.
**Why the Correct Answer is Right**
ARPKD is characterized by **congenital or early childhood onset**, bilateral renal enlargement with multiple small cysts, and **associated hepatic fibrosis**. Unlike ADPKD, it does **not** involve the PKD1 or PKD2 genes. The absence of autosomal dominant inheritance in ARPKD makes any statement suggesting this an exception.
**Why Each Wrong Option is Incorrect**
**Option A:** *If incorrect, e.g., "ARPKD is inherited in an autosomal dominant pattern"* – ARPKD is **autosomal recessive**, requiring two mutated alleles (PKHD1).
**Option B:** *If incorrect, e.g., "ARPKD is caused by mutations in PKD1 or PKD2"* – These genes cause ADPKD, not ARPKD.
**Option C:** *If incorrect, e.g., "ARPKD is asymptomatic at birth"* – ARPKD often presents with **pulmonary hypoplasia** or **jaundice** in neonates.
**Option D:** *If incorrect, e.g., "ARPKD is associated with portal hypertension due to hepatic fib